Biotech Values

[north40000]

Does look discouraging for most large caps for sure.

Agree with you re JNJ.

My wife and I hold large no. of shares of JNJ, smaller no. of BMY and PFE.

TEVA would be a good purchase by any you mention. Some of us think that AMLN and MEDX may not last long as independents.
Slowly but surely, a good many biotechs are being bought out,
MEDI and CHIR being recent, very profitable examples for me.